Floatz logo

IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER

B-cell Childhood Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)monoclonal_antibodyPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the B-cell Childhood Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
St. Jude Children's Research Hospital
Phase 3A
MERCAPTOPURINE ANHYDROUS
St. Jude Children's Research Hospital
Phase 3A
PEGASPARGASE
St. Jude Children's Research Hospital
Phase 3A
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 3BBB
METHOTREXATE
St. Jude Children's Research Hospital
Phase 3BBB

View all 44 →

Same molecule, other indications

IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER is also rated in:

relapsing-remitting multiple sclerosisDormant
BBB
Indicative ·
73 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BB
Indicative ·
71 / 100
View asset →
chronic myeloid leukemiaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →